Company / Return on Assets (ROA)
MBX Biosciences, Inc. Return on Assets (ROA) History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-23.1%
FY2024
5-year range
-38.7% / -23.1%
FY2023-FY2024
Trend
+40.4%
vs FY2023
Sector context
#108 of 213
Health Care
What the data says
At -23.1%, MBX Biosciences, Inc.'s return on assets (roa) ranks #108 of 213 in the Health Care sector.
Based on SEC 10-K filings.
-23.1% in FY2024.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#108 of 213 in Health CareTop 51% of 213This company -23.1% Sector average -24.1%
▼
+4.5% above sector average
Key checks
Key Insights
- In FY2024, return on assets (roa) increased 40.4% year-over-year.
- Currently 1.1pp above the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score 9.64 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -23.1% | +40.4% |
| FY2023 | -38.7% | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026